Continues below advertisement
Top Stories on Pharma Sector
Lifestyle
PM Modi Sets Big Pharma Target: Indian Drugmakers Should Join World’s Top Five
Business
Indian Corporate Revenue Growth Slows: Pharma, Telecom, And Airlines Buck The Trend
Business
Cipla Q1 Profit Jumps 10% To Rs 1,298 Crore, Revenue At Rs 6,957 Crore
IPO
Anthem Biosciences Makes Strong Stock Market Debut With Nearly 27 Per Cent Listing Premium
Business
India’s Healthcare Sector Maintains Growth Momentum Despite Profitability Pressures
Business
Cipla CEO Says US Drug Pricing Order Unlikely To Impact Indian Generics
Business
Which Sectors Are Most Affected By Trump Tariffs? Find Out
Business
India Engages With Domestic Pharma Exporters Amid US Tariff Concerns
Business
US Tariffs Pose Minimal Threat To Indian Pharma, Says Citi; Details Here
Business
Indian Regulator Shuts Down 36% Of Drug-Making Units: DCGI
Business
India's Domestic Drug Formulations Market Likely To Hit Rs 5.5 Trillion Mark By 2034: Report
Business
India's Stance On IPRs, Pharma in FTA Will Fosters Growth Of Generic Drug Sector: GTRI
Continues below advertisement